Approval · Notice of Compliance 29608 · 2022
FAMPYRA: Notice of Compliance 29608
Issued November 30, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 29608
- Date
- November 30, 2022
- Company
- Biogen Canada IncToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To update the inner and outer labels with correct wording of the dosage form.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FAMPYRA | Not yet assigned | — |
Medicinal ingredients
- FAMPRIDINE 10 MG per TAB